Literature DB >> 17485162

Regulation of growth hormone expression by Delta-like protein 1 (Dlk1).

Peter J Ansell1, Yunli Zhou, Brit-Maren Schjeide, Alissa Kerner, Jing Zhao, Xun Zhang, Anne Klibanski.   

Abstract

Delta-like protein 1 (Dlk1) is a transmembrane protein characterized by epidermal growth factor (EGF)-like repeats. Dlk1, which is also known as preadipocyte factor 1 (pref-1) because of its ability to inhibit preadipocyte differentiation, regulates the differentiation of several other cell types through unknown mechanisms. To elucidate Dlk1 functions, identification of Dlk1-regulated target genes is critical. The observation that Dlk1 is expressed in many endocrine tissues suggests that Dlk1 may have endocrine-related functions. Because Dlk1 is expressed in GH producing cells, we hypothesize that one function of Dlk1 is to regulate GH expression. We found that GH mRNA, protein, and secretion were significantly decreased in GH3 pituitary cell clones that stably express Dlk1. In contrast, Dlk1 expression was unable to alter prolactin expression. Co-transfection of GH3 cells with a GH promoter-regulated reporter gene showed that Dlk1 repressed GH promoter activity. Deletion and mutation analysis of the GH promoter indicated that Pit-1 binding sites in the GH promoter are required for Dlk1-mediated repression. Furthermore, Dlk1 expression represses Pit-1-mediated transcription when both proteins are co-expressed in MCF-7 cells. Deletion analysis of Dlk1 revealed that the ability of Dlk1 to regulate GH promoter activity is independent of both its EGF-like repeats and its ability to modulate MAP kinase activity. The observation that Dlk1 regulates GH expression identifies the first endocrine function of Dlk1, establishes GH as a Dlk1-regulated target gene, and provides a model system to facilitate studies of Dlk1-mediated signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485162      PMCID: PMC1974851          DOI: 10.1016/j.mce.2007.04.002

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  45 in total

Review 1.  The role of the epidermal growth factor-like protein dlk in cell differentiation.

Authors:  J Laborda
Journal:  Histol Histopathol       Date:  2000-01       Impact factor: 2.303

2.  Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation.

Authors:  C Floridon; C H Jensen; P Thorsen; O Nielsen; L Sunde; J G Westergaard; S G Thomsen; B Teisner
Journal:  Differentiation       Date:  2000-08       Impact factor: 3.880

Review 3.  POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease.

Authors:  B Andersen; M G Rosenfeld
Journal:  Endocr Rev       Date:  2001-02       Impact factor: 19.871

4.  dlk modulates mitogen-activated protein kinase signaling to allow or prevent differentiation.

Authors:  María José Ruiz-Hidalgo; Elena Gubina; Lori Tull; Victoriano Baladrón; Jorge Laborda
Journal:  Exp Cell Res       Date:  2002-04-01       Impact factor: 3.905

5.  dlk inhibits stem cell factor-induced colony formation of murine hematopoietic progenitors: Hes-1-independent effect.

Authors:  N Ohno; A Izawa; M Hattori; R Kageyama; T Sudo
Journal:  Stem Cells       Date:  2001       Impact factor: 6.277

6.  Only the large soluble form of preadipocyte factor-1 (Pref-1), but not the small soluble and membrane forms, inhibits adipocyte differentiation: role of alternative splicing.

Authors:  Baisong Mei; Ling Zhao; Li Chen; Hei Sook Sul
Journal:  Biochem J       Date:  2002-05-15       Impact factor: 3.857

7.  Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling.

Authors:  Y Zhou; H Sun; D C Danila; S R Johnson; D P Sigai; X Zhang; A Klibanski
Journal:  Mol Endocrinol       Date:  2000-12

8.  Pit-1/GHF-1 and GH expression in the MCF-7 human breast adenocarcinoma cell line.

Authors:  C Gil-Puig; M Blanco; T García-Caballero; C Segura; R Pérez-Fernández
Journal:  J Endocrinol       Date:  2002-04       Impact factor: 4.286

9.  A role for pref-1 and HES-1 in thymocyte development.

Authors:  M Kaneta; M Osawa; K Sudo; H Nakauchi; A G Farr; Y Takahama
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

10.  Fetal antigen 1 in healthy adults and patients with pituitary disease: relation to physiological, pathological, and pharmacological GH levels.

Authors:  M Andersen; C H Jensen; R K Støving; J B Larsen; H D Schrøder; B Teisner; C Hagen
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

View more
  16 in total

1.  Conditional deletions refine the embryonic requirement for Dlk1.

Authors:  Oliver K Appelbe; Aleksey Yevtodiyenko; Hilmarie Muniz-Talavera; Jennifer V Schmidt
Journal:  Mech Dev       Date:  2012-10-08       Impact factor: 1.882

2.  Analysis of the Paternally-Imprinted DLK1-MEG3 and IGF2-H19 Tandem Gene Loci in NT2 Embryonal Carcinoma Cells Identifies DLK1 as a Potential Therapeutic Target.

Authors:  Zachariah Payne Sellers; Gabriela Schneider; Magdalena Maj; Mariusz Z Ratajczak
Journal:  Stem Cell Rev Rep       Date:  2018-12       Impact factor: 5.739

3.  Inhibition of Pref-1 (preadipocyte factor 1) by oestradiol in adolescent girls with anorexia nervosa is associated with improvement in lumbar bone mineral density.

Authors:  Alexander T Faje; Pouneh K Fazeli; Debra Katzman; Karen K Miller; Anne Breggia; Clifford J Rosen; Nara Mendes; Madhusmita Misra; Anne Klibanski
Journal:  Clin Endocrinol (Oxf)       Date:  2013-07-02       Impact factor: 3.478

4.  Discovery of transcriptional regulators and signaling pathways in the developing pituitary gland by bioinformatic and genomic approaches.

Authors:  Michelle L Brinkmeier; Shannon W Davis; Piero Carninci; James W MacDonald; Jun Kawai; Debashis Ghosh; Yoshihide Hayashizaki; Robert H Lyons; Sally A Camper
Journal:  Genomics       Date:  2009-02-11       Impact factor: 5.736

5.  Analysis on cDNA sequence, mRNA expression and imprinting status of Dlk1 gene in goats.

Authors:  Guiling Cao; Yujie Zhang; Jianmin Wang; Yunliang Jiang
Journal:  Mol Biol Rep       Date:  2009-08-18       Impact factor: 2.316

6.  The spatial and temporal expression of delta-like protein 1 in the rat pituitary gland during development.

Authors:  Takashi Nakakura; Misa Sato; Masakazu Suzuki; Osamu Hatano; Hiroshi Takemori; Yukio Taniguchi; Yukinori Minoshima; Shigeyasu Tanaka
Journal:  Histochem Cell Biol       Date:  2008-08-27       Impact factor: 4.304

7.  Prenatal notch1 receptor blockade by protein delta homolog 1 (DLK1) modulates adipocyte size in vivo.

Authors:  T M Kilian; N Klöting; M Blüher; A G Beck-Sickinger
Journal:  Int J Obes (Lond)       Date:  2015-08-26       Impact factor: 5.095

8.  The adaptor SASH1 acts through NOTCH1 and its inhibitor DLK1 in a 3D model of lumenogenesis involving CEACAM1.

Authors:  Kandis Stubblefield; Jennifer Chean; Tung Nguyen; Charng-Jui Chen; John E Shively
Journal:  Exp Cell Res       Date:  2017-08-18       Impact factor: 3.905

9.  DLK1/PREF1 regulates nutrient metabolism and protects from steatosis.

Authors:  Marika Charalambous; Simao Teixeira Da Rocha; Elizabeth Jane Radford; Gema Medina-Gomez; Scott Curran; Scarlett B Pinnock; Sacri R Ferrón; Antonio Vidal-Puig; Anne C Ferguson-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-27       Impact factor: 11.205

10.  Pituitary phenotypes of mice lacking the notch signalling ligand delta-like 1 homologue.

Authors:  L Y M Cheung; K Rizzoti; R Lovell-Badge; P R Le Tissier
Journal:  J Neuroendocrinol       Date:  2013-04       Impact factor: 3.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.